Related Experiment Video
Updated: May 29, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Functional characterization of pfm in protein secretion and lung infection of Pseudomonas aeruginosa
Fang Bai1, Haijin Xu, Qi Zhang
1College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, People's Republic of China.
Abstract:
Lung infections caused by Pseudomonas aeruginosa in cystic fibrosis (CF) patients cause progressive airway obstruction and tissue damage, which is the predominant cause of morbidity and mortality in patients with CF. This paper describes the functional characterization of the pfm gene (open reading frame PA2950) of P. aeruginosa. Using DNA microarrays, we found that the transcriptional levels of type II secretory system genes were significantly reduced in the pfm mutant strain. The type-II-dependent exoprotein LasB could not be secreted normally. The pfm gene was identified as a gene involved in bacterial protein secretion that was critical for the extracellular release of elastase in P. aeruginosa. The abilities to induce lung injury by wild-type and pfm mutant P. aeruginosa were evaluated in a murine acute lung infection model. The results showed that the pathogenicity and virulence of the pfm mutant strain was significantly reduced compared with that of the wild-type strain. The pfm gene and its expression product, as potential new drug targets against P. aeruginosa infection, have important research significance.
Insights
Pseudomonas aeruginosa lung infections are deadly in cystic fibrosis (CF) patients. A study found the pfm gene is crucial for P. aeruginosa virulence, suggesting it as a potential drug target to combat CF infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Pseudomonas aeruginosa lung infections cause significant morbidity and mortality in cystic fibrosis (CF) patients.
- Understanding the genetic factors contributing to P. aeruginosa virulence is critical for developing effective treatments.
Purpose of the Study:
- To functionally characterize the pfm gene (PA2950) in P. aeruginosa.
- To investigate the role of the pfm gene in bacterial protein secretion and pathogenicity.
Main Methods:
- DNA microarrays were used to analyze gene expression in a pfm mutant strain.
- The secretion of type-II-dependent exoproteins, such as LasB elastase, was assessed.
- A murine acute lung infection model was employed to evaluate the virulence of wild-type and pfm mutant strains.
Main Results:
- The pfm mutant showed significantly reduced transcriptional levels of type II secretory system genes.
- Secretion of the exoprotein LasB was impaired in the pfm mutant.
- The pfm mutant strain exhibited significantly reduced pathogenicity and virulence in a murine lung infection model.
Conclusions:
- The pfm gene is essential for the extracellular release of elastase and critical for P. aeruginosa virulence.
- The pfm gene and its product represent potential novel drug targets for treating P. aeruginosa infections, particularly in CF patients.
Related Concept Videos
Atypical Pneumonia
Gene Regulation in Microbial Communities: Quorum Sensing
Pneumonia II: Pathophysiology

